142 related articles for article (PubMed ID: 1743558)
1. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
[TBL] [Abstract][Full Text] [Related]
2. [Serum CA 125 and ferritin in patients with ovarian carcinoma].
Kanajet D; Klarić P; Filjak K
Jugosl Ginekol Perinatol; 1988; 28(5-6):125-8. PubMed ID: 3216687
[No Abstract] [Full Text] [Related]
3. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
[TBL] [Abstract][Full Text] [Related]
4. Value of serum 125Ca levels: does the result preclude second look?
Potter ME; Moradi M; To AC; Hatch KD; Shingleton HM
Gynecol Oncol; 1989 May; 33(2):201-3. PubMed ID: 2703182
[TBL] [Abstract][Full Text] [Related]
5. A study of serum CASA and CA 125 levels in patients with ovarian carcinoma.
Meisel M; Straube W; Weise J; Burkhardt B
Arch Gynecol Obstet; 1995; 256(1):9-15. PubMed ID: 7726659
[TBL] [Abstract][Full Text] [Related]
6. Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma.
Geisler JP; Miller GA; Lee TH; Harwood RM; Wiemann MC; Geisler HE
J Reprod Med; 1996 Mar; 41(3):140-2. PubMed ID: 8778409
[TBL] [Abstract][Full Text] [Related]
7. Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Reichman BS; Chapman D; Lewis JL
Am J Obstet Gynecol; 1989 Mar; 160(3):667-71. PubMed ID: 2648838
[TBL] [Abstract][Full Text] [Related]
8. Epithelial ovarian carcinoma of low malignant potential.
Darai E; Teboul J; Walker F; Benifla JL; Meneux E; Guglielmina JN; Pennehouat G; Renolleau C; Sebban E; Madelenat P
Eur J Obstet Gynecol Reprod Biol; 1996 Jun; 66(2):141-5. PubMed ID: 8735736
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
10. [Serum level of the tumor marker CA 125 before second-look laparatomy in primary epithelial ovarian cancer in relation to intraoperative findings].
Meden H; Rath W; Teichmann A; Kuhn W
Onkologie; 1989 Oct; 12(5):217-20. PubMed ID: 2685687
[TBL] [Abstract][Full Text] [Related]
11. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
Chi DS; Venkatraman ES; Masson V; Hoskins WJ
Gynecol Oncol; 2000 May; 77(2):227-31. PubMed ID: 10785469
[TBL] [Abstract][Full Text] [Related]
12. Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence.
Schilthuis MS; Aalders JG; Bouma J; Kooi H; Fleuren GJ; Willemse PH; De Bruijn HW
Br J Obstet Gynaecol; 1987 Mar; 94(3):202-7. PubMed ID: 3471274
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum CA-125 levels in early stage ovarian cancer.
Patsner B
Eur J Gynaecol Oncol; 1990; 11(5):319-21. PubMed ID: 2097148
[TBL] [Abstract][Full Text] [Related]
14. [Epithelial ovarian cancer--preoperative assessment of Ca 125 levels as an independent prognostic factor].
Ivanov S; Ivanov S
Akush Ginekol (Sofiia); 2003; 42(3):16-9. PubMed ID: 12858485
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma.
Gadducci A; Ferdeghini M; Ceccarini T; Prontera C; Facchini V; Bianchi R; Fioretti P
Eur J Gynaecol Oncol; 1990; 11(2):127-33. PubMed ID: 2379512
[TBL] [Abstract][Full Text] [Related]
16. Serum copper in ovarian carcinoma.
Jacobs AJ; Sommers GM; Axelrod JH; Galakatos AE; Kao MS; Camel HM
Cancer; 1988 Mar; 61(5):1015-7. PubMed ID: 3422179
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
Vardi JR; Tadros GH; Foemmel R; Shebes M
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
Gynecol Oncol; 1989 Oct; 35(1):44-6. PubMed ID: 2792900
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A
Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653
[TBL] [Abstract][Full Text] [Related]
20. CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer.
Sevelda P; Schemper M; Spona J
Am J Obstet Gynecol; 1989 Nov; 161(5):1213-6. PubMed ID: 2589442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
